Neuronetics, Inc. Files 8-K: Material Agreement and Other Events
Ticker: STIM · Form: 8-K · Filed: Feb 10, 2025 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Feb 10, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $2.25, $16.355 million, $18.893 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k, filing
TL;DR
Neuronetics filed an 8-K on Feb 10th, reporting a material agreement and other events from Feb 7th.
AI Summary
On February 7, 2025, Neuronetics, Inc. entered into a Material Definitive Agreement. The company also reported other events and filed financial statements and exhibits. The filing was made on February 10, 2025.
Why It Matters
This 8-K filing indicates a significant event for Neuronetics, Inc., likely involving a new contract or partnership that could impact its business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the nature of these events requires further investigation.
Key Numbers
- 001-38546 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- February 7, 2025 (date) — Date of earliest event reported
- February 10, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 3222 Phoenixville Pike, Malvern, PA 19355 (address) — Principal executive offices
FAQ
What is the nature of the Material Definitive Agreement entered into by Neuronetics, Inc. on February 7, 2025?
The filing states that Neuronetics, Inc. entered into a Material Definitive Agreement on February 7, 2025, but the specific details of this agreement are not provided in the provided text.
What are the 'Other Events' reported by Neuronetics, Inc. in this 8-K filing?
The filing mentions 'Other Events' as a category of information being reported, but the specific details of these events are not elaborated upon in the provided text.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on February 10, 2025.
What is Neuronetics, Inc.'s principal executive office address?
Neuronetics, Inc.'s principal executive office is located at 3222 Phoenixville Pike, Malvern, PA 19355.
What is the SIC code for Neuronetics, Inc.?
The Standard Industrial Classification (SIC) code for Neuronetics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 1,176 words · 5 min read · ~4 pages · Grade level 12.5 · Accepted 2025-02-07 18:12:51
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M
- $2.25 — on Stock"), at a price to the public of $2.25 per share (the "Offering"). Under the t
- $16.355 million — ffering expenses, will be approximately $16.355 million (or $18.893 million including the Optio
- $18.893 million — ll be approximately $16.355 million (or $18.893 million including the Option Shares). The Compa
Filing Documents
- d928209d8k.htm (8-K) — 32KB
- d928209dex11.htm (EX-1.1) — 199KB
- d928209dex51.htm (EX-5.1) — 6KB
- d928209dex991.htm (EX-99.1) — 11KB
- d928209dex992.htm (EX-99.2) — 12KB
- g928209dsp1.jpg (GRAPHIC) — 3KB
- g928209dsp1a.jpg (GRAPHIC) — 4KB
- 0001193125-25-022833.txt ( ) — 457KB
- stim-20250207.xsd (EX-101.SCH) — 3KB
- stim-20250207_lab.xml (EX-101.LAB) — 17KB
- stim-20250207_pre.xml (EX-101.PRE) — 11KB
- d928209d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 1.1 Underwriting Agreement, dated as of February 7, 2025, by and between Neuronetics, Inc. and Canaccord Genuity LLC 5.1 Opinion of Ballard Spahr LLP 23.1 Consent of Ballard Spahr LLP (contained in Exhibit 5.1 above) 99.1 Press release issued by Neuronetics, Inc. on February 6, 2025 99.2 Press release issued by Neuronetics, Inc. on February 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEURONETICS, INC. (Registrant) Date: February 7, 2025 By: /s/ Stephen Furlong Name: Stephen Furlong Title: EVP, Chief Financial Officer and Treasurer